Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Wei Zhen Yeh, MBBS https://orcid.org/0000-0002-5335-6612, Putu Ayu Widyastuti, BMedSci(Hons), Anneke Van der Walt, PhD https://orcid.org/0000-0002-4278-7003, Jim Stankovich, PhD, Eva Havrdova, MD, Dana Horakova, MD, Karolina Vodehnalova, MD https://orcid.org/0000-0002-0675-2866, … Show All … , Serkan Ozakbas, MD, Sara Eichau, MD, Pierre Duquette, MD, Tomas Kalincik, PhD https://orcid.org/0000-0003-3778-1376, Francesco Patti, MD, Cavit Boz, MD, Murat Terzi, MD, Bassem I. Yamout, MD, Jeannette Lechner-Scott, MD, Patrizia Sola, MD https://orcid.org/0000-0002-1700-1726, Olga G. Skibina, MD, Michael Barnett, MBBS https://orcid.org/0000-0002-2156-8864, Marco Onofrj, MD, Maria José Sá, MD, Pamela Ann McCombe, MBBS, Pierre Grammond, MD, Radek Ampapa, MD, Francois Grand'Maison, MD https://orcid.org/0000-0003-0091-0074, Roberto Bergamaschi, MD, Daniele L.A. Spitaleri, MD, Vincent Van Pesch, MD https://orcid.org/0000-0003-2885-9004, Elisabetta Cartechini, MD, Suzanne Hodgkinson, MD, Aysun Soysal, MD, Albert Saiz, MD, Melissa Gresle, PhD, Tomas Uher, PhD https://orcid.org/0000-0003-3160-9022, Davide Maimone, MD, Recai Turkoglu, MD https://orcid.org/0000-0001-9724-851X, Raymond M.M. Hupperts, MD, Maria Pia Amato, MD, Franco Granella, MD, Celia Oreja-Guevara, MD, Ayse Altintas, MD, Richard A. Macdonell, MD, Tamara Castillo-Trivino, MD, Helmut Butzkueven, PhD, Raed Alroughani, MD, and Vilija G. Jokubaitis, PhD https://orcid.org/0000-0002-3942-4340 on behalf of the MSBase Study Group Show FewerAuthors Info & Affiliations
Abstract
Objective
To investigate pregnancy-related disease activity in a contemporary multiple sclerosis (MS) cohort.
Methods
Using data from the MSBase Registry, we included pregnancies conceived after December 31, 2010, in women with relapsing-remitting MS or clinically isolated syndrome. Predictors of intrapartum relapse and postpartum relapse and disability progression were determined by clustered logistic regression or Cox regression analyses.
Results
We included 1,998 pregnancies from 1,619 women with MS. Preconception annualized relapse rate (ARR) was 0.29 (95% confidence interval 0.27–0.32), fell to 0.19 (0.14–0.24) in the third trimester, and increased to 0.59 (0.51–0.67) in early postpartum. Among women who used fingolimod or natalizumab, ARR before pregnancy was 0.37 (0.28–0.49) and 0.29 (0.22–0.37), respectively, and increased during pregnancy. Intrapartum ARR decreased with preconception dimethyl fumarate use. ARR spiked after delivery across all DMT groups. Natalizumab continuation into pregnancy reduced the odds of relapse during pregnancy (odds ratio 0.76 per month [0.60–0.95], p = 0.017). DMT reinitiation with natalizumab protected against postpartum relapse (hazard ratio [HR] 0.11 [0.04–0.32], p < 0.0001). Breastfeeding women were less likely to relapse (HR 0.61 [0.41–0.91], p = 0.016). We found that 5.6% of pregnancies were followed by confirmed disability progression, predicted by higher relapse activity in pregnancy and postpartum.
Conclusion
Intrapartum and postpartum relapse probabilities increased among women with MS after natalizumab or fingolimod cessation. In women considered to be at high relapse risk, use of natalizumab before pregnancy and continued up to 34 weeks gestation with early reinitiation after delivery is an effective option to minimize relapse risks. Strategies of disease-modifying therapy use have to be balanced against potential fetal/neonatal complications.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Wallin MT, Culpepper WJ, Nichols E, et al. Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:269-285.
2.
Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis: Pregnancy in Multiple Sclerosis Group. N Engl J Med. 1998;339:285-291.
3.
Nguyen AL, Eastaugh A, van der Walt A, Jokubaitis VG. Pregnancy and multiple sclerosis: clinical effects across the lifespan. Autoimmun Rev. 2019;18:102360.
4.
Karp I, Manganas A, Sylvestre M-P, Ho A, Roger E, Duquette P. Does pregnancy alter the long-term course of multiple sclerosis? Ann Epidemiol. 2014;24:504-508.e2.
5.
De Angelis F, John NA, Brownlee WJ. Disease-modifying therapies for multiple sclerosis. BMJ. 2018;363:k4674.
6.
Alroughani R, Akhtar S, Zeineddine M, et al. Risk of relapses during pregnancy among multiple sclerosis patients. Mult Scler Relat Disord. 2019;34:9-13.
7.
Bsteh G, Algrang L, Hegen H, et al. Pregnancy and multiple sclerosis in the DMT era: a cohort study in Western Austria. Mult Scler. 2020;26:69-78.
8.
Alroughani R, Alowayesh MS, Ahmed SF, Behbehani R, Al-Hashel J. Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era. Neurology. 2018;90:e840-e846.
9.
Berenguer-Ruiz L, Gimenez-Martinez J, Palazón-Bru A, Sempere AP. Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy. J Neurol. 2019;266(10):2512-2517.
10.
Kalincik T, Butzkueven H. The MSBase registry: informing clinical practice. Mult Scler J. 2019;25(14):1828-1834.
11.
Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162-173.
12.
Tur C, Kalincik T, Oh J, et al. Head-to-head drug comparisons in multiple sclerosis: urgent action needed. Neurology. 2019;93:793-809.
13.
R Core Team. R: A Language and Environment for Statistical Computing [online]. R Foundation for Statistical Computing; 2019. Available at: R-project.org/.
14.
Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4:1686.
15.
Robitzsch A, Grund S. Miceadds: Some Additional Multiple Imputation Functions, Especially for “Mice”; 2019. Available at: CRAN.R-project.org/package=miceadds.
16.
Zeileis A. Econometric computing with HC and HAC covariance matrix estimators. J Stat Softw. 2004;11:1-17.
17.
Zeileis A. Object-oriented computation of sandwich estimators. J Stat Softw. 2006;16:1-16.
18.
Berger S, Graham N, Zeileis A. Various Versatile Variances: An Object-Oriented Implementation of Clustered Covariances in R. Faculty of Economics and Statistics, University of Innsbruck; 2017. Available at: econpapers.repec.org/paper/innwpaper/2017-12.htm. Accessed September 9, 2020.
19.
Therneau TM. A Package for Survival Analysis in R; 2015. Available at: CRAN.R-project.org/package=survival.
20.
Sorensen PS, Sellebjerg F, Hartung HP, Montalban X, Comi G, Tintoré M. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history. Brain. 2020;143:2637-2652.
21.
O'Connor PW, Goodman A, Kappos L, et al. Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology. 2011;76:1858-1865.
22.
Friend S, Richman S, Bloomgren G, Cristiano LM, Wenten M. Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study. BMC Neurol. 2016;16:150.
23.
Haghikia A, Langer-Gould A, Rellensmann G, et al. Natalizumab use during the third trimester of pregnancy. JAMA Neurol Am Med Assoc. 2014;71:891-895.
24.
Dobson R, Dassan P, Roberts M, Giovannoni G, Nelson-Piercy C, Brex PA. UK consensus on pregnancy in multiple sclerosis: “Association of British Neurologists” guidelines. Pract Neurol. 2019;19:106-114.
25.
Meinl I, Havla J, Hohlfeld R, Kümpfel T. Recurrence of disease activity during pregnancy after cessation of fingolimod in multiple sclerosis. Mult Scler J. 2018;24:991-994.
26.
Karlsson G, Francis G, Koren G, et al. Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology. 2014;82:674-680.
27.
Gold R, Phillips JT, Havrdova E, et al. Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience. Neurol Ther. 2015;4:93-104.
28.
Mehta D, Miller C, Arnold DL, et al. Effect of dimethyl fumarate on lymphocytes in RRMS: implications for clinical practice. Neurology. 2019;92:e1724-e1738.
29.
Langer-Gould A, Smith JB, Albers KB, et al. Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort. Neurology. 2020;94:e1939-e1949.
30.
Miller DH, Khan OA, Sheremata WA, et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003;348:15-23.
31.
Butzkueven H, Licata S, Jeffery D, et al. Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study. BMJ Open. 2020;10:e038861.
32.
Oh J, Achiron A, Celius EG, et al. Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Mult Scler Relat Disord. 2020;43:102146.
33.
Baker D, Pryce G, Amor S, Giovannoni G, Schmierer K. Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis. Brain. 2018;141:2834-2847.
34.
Juto A, Fink K, Al Nimer F, Piehl F. Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity. Mult Scler Relat Disord. 2020;37:101468.
35.
Kümpfel T, Thiel S, Meinl I, et al. Anti-CD20 therapies and pregnancy in neuroimmunologic disorders. Neurol Neuroimmunol Neuroinflamm. 2020;8:e913.
36.
Smith JB, Hellwig K, Fink K, Lyell DJ, Piehl F, Langer-Gould A. Rituximab, MS, and pregnancy. Neurol Neuroimmunol Neuroinflamm. 2020;7:e734.
37.
Das G, Damotte V, Gelfand JM, et al. Rituximab before and during pregnancy. Neurol Neuroimmunol Neuroinflamm. 2018;5:e453.
38.
Razaz N, Piehl F, Frisell T, Langer-Gould AM, McKay KA, Fink K. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab. Neurol Neuroimmunol Neuroinflamm. 2020;7:e903.
39.
Krysko KM, Rutatangwa A, Graves J, Lazar A, Waubant E. Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis. JAMA Neurol. 2020;77:327.
40.
Krysko KM, LaHue SC, Anderson A, et al. Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions. Neurol Neuroimmunol Neuroinflamm. 2020;7:e637.
41.
Ciplea AI, Langer-Gould A, de Vries A, et al. Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2020;7:e723.
42.
Kalincik T, Cutter G, Spelman T, et al. Defining reliable disability outcomes in multiple sclerosis. Brain. 2015;138:3287-3298.
43.
Portaccio E, Ghezzi A, Hakiki B, et al. Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. J Neurol Neurosurg Psychiatry. 2014;85:845-850.
44.
Jokubaitis VG, Spelman T, Kalincik T, et al. Predictors of long-term disability accrual in relapse-onset multiple sclerosis. Ann Neurol. 2016;80:89-100.
Information & Authors
Information
Published In
Copyright
© 2021 American Academy of Neurology.
Publication History
Received: October 28, 2020
Accepted: March 17, 2021
Published online: April 20, 2021
Published in print: June 15, 2021
Permissions
Request permissions for this article.
Disclosure
W.Z. Yeh reports research support from Multiple Sclerosis Research Australia and the Australian Government Research Training Program during the conduct of the study, as well as speaker honoraria and conference attendance support from Biogen and travel support from Merck, outside of the submitted work. P.A. Widyastuti, A. Van der Walt, J. Stankovich, and E. Havrdova report no disclosures. D. Horakova received compensation for travel, speaker honoraria, and consultant fees from Biogen, Novartis, Merck, Bayer, Sanofi, Roche, and Teva, as well as support for research activities from Biogen and support by the Czech Ministry of Education project Progress Q27/LF1. K. Vodehnalova received compensation for traveling, conference fees, and consulting fees from Merck, Teva, Sanofi Genzyme, Biogen Idec, Novartis, and Roche S. Ozakbas reports no disclosures S. Eichau received speaker honoraria and consultant fees from Biogen Idec, Novartis, Merck, Bayer, Sanofi Genzyme, Roche, and Teva P. Duquette reports no disclosures. T. Kalincik served on scientific advisory boards for Roche, Sanofi Genzyme, Novartis, Merck, and Biogen and steering committee for Brain Atrophy Initiative by Sanofi Genzyme; received conference travel support and/or speaker honoraria from WebMD Global, Novartis, Biogen, Sanofi-Genzyme, Teva, BioCSL, and Merck; and received research or educational event support from Biogen, Novartis, Genzyme, Roche, Celgene, and Merck. F. Patti received personal compensations for talks and serving on advisory boards by Almirall, Bayer, Biogen, Celgene, Merck, Novartis, Roche, Sanofi-Genzyme, and Teva and received research grants from Biogen, Merck, Fondazione Italiana Sclerosi Multipla, Reload Onlus Association, and University of Catania. C. Boz, M. Terzi, and B.I. Yamout report no disclosures. J. Lechner-Scott has accepted travel compensation from Novartis, Biogen, Roche, and Merck. Her institution receives the honoraria for talks and advisory board commitment as well as research grants from Biogen, Merck, Roche, Teva, and Novartis. P. Sola, O.G. Skibina, M. Barnett, M. Onofrj, M.J. Sá, P.A. McCombe, P. Grammond, R. Ampapa, F. Grand'Maison, R. Bergamaschi, and D.L.A. Spitaleri report no disclosures. V. Van Pesch has received travel grants from Merck, Biogen, Sanofi, Celgene, Almirall, and Roche. His institution has received research grants and consultancy fees from Roche, Biogen, Sanofi, Celgene, Merck, and Novartis Pharma. E. Cartechini received speaker honoraria and travel grants from Novartis, Roche, and Sanofi-Genzyme. S. Hodgkinson and A. Soysal report no disclosures. A. Saiz received compensation for consulting services and speaking honoraria from Merck-Serono, Biogen Idec, Sanofi-Aventis, Teva, Roche, Novartis, and Alexion. M. Gresle reports no disclosures. T. Uher received financial support for conference travel and honoraria from Biogen Idec, Novartis, Roche, Genzyme, and Merck Serono, as well as support for research activities from Biogen Idec and Sanofi. D. Maimone received speaker honoraria for advisory board and travel grants from Almirall, Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, and Teva. R. Turkoglu, R.M.M. Hupperts, M.P. Amato, and F. Granella report no disclosures. C. Oreja-Guevara received personal compensations for talks and serving on advisory boards from Biogen, Celgene, Merck, Novartis, Roche, Sanofi-Genzyme, and Teva. A. Altintas and R.A. Macdonell report no disclosures. T. Castillo-Triviño received speaking/consulting fees and/or travel funding from Bayer, Biogen, Merck, Novartis, Roche, Sanofi-Genzyme, and Teva. H. Butzkueven's institution received compensation for advisory board, steering committee, and educational activities from Biogen, Roche, Merck, and Novartis. His institution received research support from Roche, Novartis, Biogen, NHMRC, Medical Research Future Fund Australia, and MS Research Australia. He received personal compensation from Oxford HPF for serving on the steering group of MS Brain Health. R. Alroughani reports no disclosures. V.G. Jokubaitis received conference travel support from Merck and Roche and speaker’s honoraria from Biogen and Roche outside of the submitted work. She receives research support from the Australian National Health and Medical Research Grant (NHMRC GNT1156519) and MS Research Australia (grants 18-0424, 19-0665). Go to Neurology.org/N for full disclosures.
Study Funding
Funding provided by the NHMRC of Australia, grant 1156519; Multiple Sclerosis Research Australia Postgraduate Scholarship, No. 19-0735; and Australian Government Research Training Program Scholarship. MSBase is a not-for-profit organization that receives support from Roche, Merck, Biogen, Novartis, Bayer-Schering, Sanofi Genzyme, and Teva.
Authors
Affiliations & Disclosures
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Biogen, speaker honoraria and conference attendance support. (2) Merck, travel support.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
(1) Department of Education, Skills and Employment, Australian Government, Research Training Program Scholarship, 2019-2022
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
(1) Multiple Sclerosis Research Australia, Grant ID 19-0735, Postgraduate Scholarship
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Putu Ayu Widyastuti, BMedSci(Hons)
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1) Alexion scientific advisory board (2) Novartis scientific advisory board (3) NervGen scientific advisory board (4) Biogen scientific advisory board (5) Roche scientific advisory board
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Biogen Idec, Roche, Merck, Novartis Australia - travel support and speaker's honoraria
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
(1) Employed as the Chief Operating Officer of the MSBase Foundation.
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1)Biogen Idec;Novartis Australia, Roche
Research Support, Government Entities:
1.
(1) NHMRC Investigator Grant no 1196380:2021-2026; (2) Trish Grant 19-0665,2020-2022, CIA (3) MSRA Project Grant ANZAN MSNI COVID-19 Registry, 2020, CIA (4) NHMRC Project Grant 1142353, 2018-2021, CIB
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jim Stankovich, PhD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Eva Havrdova, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
1. Biogen 2. Novartis 3. Genzyme 4. Actelion 5. Celgene
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
1. Biogen 2. Novartis 3. Celgene 4. Genzyme 5. Actelion 6. Roche 7. Merck Serono
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
1. Biogen 2. Novartis 3. Celgene 4. Genzyme 5. Actelion 6. Roche 7. Merck Serono
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
1. European Commission Grant: ABIRISK - IMI (2012-2016), investigator 2. Czech Ministry of Education: PROGRES Q27/LF1 (2017- 2022), investigator
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
Biogen - Expert witness, 2019
Dana Horakova, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Dr. Horakova received compensation for travel, speaker honoraria and consultant fees from Biogen Idec, Novartis, Merck, Bayer, Sanofi Genzyme, Roche, and Teva.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Support for research activities from Biogen Idec.
Research Support, Government Entities:
1.
Support by the Czech Ministry of Education project Progres Q27/LF1.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
I received compensation for traveling, conference fees from Merck, Teva, Sanofi Genzyme, Biogen Idec, Novartis, Roche. Payment was always provided directly to the organizer of the educational event and to the transport carriers. I never received cash.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
I recieved 2-years grant from Charles University Grant Agency in 2020.
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Serkan Ozakbas, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Sara Eichau, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1)Biogen, (2)Merck, (3)Novartis, (4)Almirall, (5)Roche, (6)Sanofi
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Sara Eichau received speaker honoraria and funding for travel from (1)Biogen, (2)Merck, (3)Novartis, (4)Almirall, (5)Roche, (6)Sanofi and (7)Teva
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1)Biogen, (2)Merck, (3)Novartis, (4)Almirall, (5)Roche, (6)Sanofi
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Pierre Duquette, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Member of advisory boards for Biogen-Idec, EMD Serono, Novartis, TEVANeuroscience, Genzyme.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
Shared patent for a cellular adhesion molecule.
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Organisation of CME activities with Biogen-Idec, EMD Serono, Novartis, TEVANeuroscience, Genzyme.
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Investigator-initiated studies funded by Biogen-Idec, by Novartis,EMD Serono, and by Genzyme.
Research Support, Government Entities:
1.
CIHR grant (co-investigator). MS Society of Canada (co-investigator).
Research Support, Academic Entities:
1.
MS Society of Canada.
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1) chair of the MSBase Scientific Leadership Group, (2) Novartis, (3) Merck, (4) Biogen, (5) Roche, (6) Genzyme-Sanofi, (7) Celgene
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Novartis, compensation for travel and speaker honoraria (2) Biogen, compensation for travel and speaker honoraria (3) Genzyme-Sanofi, compensation for travel and speaker honoraria (4) Teva, speaker honoraria (5) Merck, compensation for travel and speaker honoraria (6) WebMD Global, speaker honoraria (7) Roche, speaker honoraria (8) BioCSL, speaker honoraria
Editorial Boards:
1.
(1) Multiple Sclerosis Journal, editorial board member, since 2018 (2) CNS Drugs, editorial board member, since 2020 (3) Neurology and Clinical Practice, editorial board member, since 2020 (4) BMC Neurology, associate editor 2017-2018 (5) Frontiers in Neurology, reviewer editor 2017-2018
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
(1) Novartis, (2) Biogen, (3) Genzyme-Sanofi, (4) Teva, (5) Merck, (6) WebMD Global, (7) Roche, (8) BioCSL, (9) Roche, (10) BMS/Celgene
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Biogen, (2) Merck, (3) BMS/Celgene
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
(1) National Health and Medical Research Council, (2) MS Research Australia, (3) Medical Research Future Fund, (4) Australian Research Council, (5) MS Society, UK, (6) EDMUS and ARSEP Foundations
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Francesco Patti, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
I served as advisory board member in the following companies: Almirall, Bayer, Biogen, Bristol Meyers Squibb, Celgene, Merck, Novartis, Roche, Sanofi and TEVA I received unconditioned research grant by Biogen and Merck I received research grant by RELOAD Onlus Association, and FISM I received research grants by University of Catania
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
I received speaker honoraria from Almirall and Bayer in 2014, and 2015, and 2016, from Novartis in 2013, 2014 and 2015,2016 from TEVA in 2013, 2014 and 2015, 208, 2019 from Biogen in 2013, 2014 and 2015, 2016, 2017, 2019 and 2020 I received speaking honoraria from Roche in 2018 and 2019 and from Sanofi in 2017, 2018 and 2019
Editorial Boards:
1.
I serve BMC Neurology as Senior Editor; I serve Multiple Sclerosis Hindawi as associate editor; I serve Frontiers in Neurology as associate editor; I serve Neurology and Therapy as Associate editor
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
I received personal compensation from: Almirall, Bayer, Biogen, Merck Serono, Novartis, Roche, Sanofi-Genzyme, TEVA
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
Grant from University of Catania (2007-2008-2009-2010- 2011, 2015, 2017, 2018, 2020)
Research Support, Foundations and Societies:
1.
Grant from FISM (2010, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019)
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Cavit Boz, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
has received travel grants from Merck Serono, Biogen Idec, Novartis, Bayer-Schering, Merck-Serono and Teva; has participated in clinical trials by Sanofi Aventis, Roche and Novartis.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Murat Terzi, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
received travel grants from Novartis, Bayer Schering, Merck Serono and Teva
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
has participated in clinical trials by Sanofi Aventis, Roche and Novartis.
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Bassem I. Yamout, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Served on scientific advisory boards for Merck, Biogen, Novartis, Sanofi, Roche
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
has received honoraria for speaking and consulting for Biogen, Novartis, Sanofi, Roche, Merck and Bayer
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
has received honoraria for speaking and consulting for Biogen, Novartis, Sanofi, Roche, Merck and Bayer
Speakers' Bureaus:
1.
has received honoraria for speaking and consulting for Biogen, Novartis, Sanofi, Roche, Merck and Bayer
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Novartis, Merck, Sanofi Genzyme, Bayer, Biogen and Roche.
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Jeannette Lechner-Scott, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1)On advisory board for Biogen (2) Novartis (3) Merck (4) Roche
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Merck travel and speaker compensation (2) Novartis speaker compensation
Editorial Boards:
1.
Chief editor of Multiple Sclerosis and Related Disorder
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Merck (2) Biogen
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
(1) expert witness for Novartis
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Olga G. Skibina, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Have worked on advisory boards of Roche, Merck, Sanofi Genzyme
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
1.Travel grants from Roche, Sanofi Gezyme and Merck 2. Speaker honoraria from Sanofi Genzime, Merck, Novartis
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
1) Sydney Neuroimaging Analysis Centre 2) RxMx Corporation
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
1) Novartis, institutional research support 2) Roche, institutional research support 3) Biogen, institutional research support 4) BMS/Celgene, institutional research support
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
Sydney Neuroimaging Analysis Centre
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Marco Onofrj, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
GSK, member of advisory board, 2003 and 2008. Novartis, member of advisory board, 2006-2008. Lundbeck, member of advisory board, 2007. EISAI, member of advisory board, 2003. Valeant, member of advisory board, 2005. Medtronic, member of advisory board, 2009. Newron, member of advisory board, 2005-2009.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Movement Disorder Society,speaker for congresses 2008,2012,2013 World Parkinson Congress 2015 Mental Disorders in Parkinson Disease 2016 Atypical Dementias congress 2017
Editorial Boards:
1.
Section Editor,Neurology,for the journal
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
Boehringer/Inghelheim, speaker in CME conferences, 2007- 2009. GSK, speaker in CME conferences, 2007-2009. UCB, speaker in CME conferences, 2009. Zambon,Safinamide,speaker in CME conference 2016,2017,2020
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Italian Ministry of Health and Italian Ministry of Education/ grants (no number available) for reasearch on dementia, epilepsy, parkinsonism, multiple sclerosis, principal investigator, 1994-2018.
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Maria José Sá, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Pamela Ann McCombe, MBBS
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Scientific advisory board for Biogen, Merck, Novartis
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
Frontiers in Neurology Associate Editor
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Pierre Grammond, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1) Biogen idec (2) Merk Serono (3) Roche (4) Novartis (5) Alexion
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Funding for travel to congress followed by a speak on a congress, Biogen idec
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Biogen Idec (2) Roche
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
(1) MSBase Foundation
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Radek Ampapa, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Scientific advisory board for Novartis, Roche, Biogen and Merck.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Travel compensation from Biogen, Merck and Sanofi.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Commercial entities: Serono, Biogen, Novartis, Roche,Sanofi, Alexion
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Ad board for Alexion and Roche. Honoraria.
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Commercial entities: Novartis, Genzyme, Mitsubishi, BiogenIdec, Sanofi, Genetech, Chugai, Opexa Therapeutics
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Roberto Bergamaschi, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
RB has served on scientific advisory boards for Biogen Idec, Merck-Serono, Novartis, Sanofi-Genzyme
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
RB received funding for travels and congresses from Almirall, Biogen, Roche, Merck-Serono, Sanofi-Genzyme, Teva received honoraria for speaking engagement Biogen, Merck- Serono, Novartis, Sanofi-Genzyme
Editorial Boards:
1.
BMC Neurology, Associated Editor, 2011-2016 Multiple Sclerosis International, Editorial board member, 2011 Clinical Forum, Editorial board member, 2010
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
RB received research support from Bayer, Almirall, Biogen, Merck-Serono, Novartis, Roche, Sanofi-Genzyme
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Daniele L.A. Spitaleri, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1) C.I.C. Edizioni Internazionali
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Novartis, (2) Bayer, (3) Biogen, (4) TEVA, (5) Merck- Serono, (6) Sanofi-Aventis
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1)Novartis, (2)Bayer, (3) Sanofi-Aventis
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Merck-Serono (2) Novartis (3) Schering
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1) Biogen (2)Sanofi (3) Roche (4) Novartis Pharma (5) Merck (6) BMS (7) Almirall
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Biogen: travel funding and speaker honoraria (2)Sanofi: travel funding and speaker honoraria (3) Merck: travel funding (4) Roche: travel funding and speaker honoraria (5) BMS: travel funding (6) Almirall: travel funding
Editorial Boards:
1.
(1) Acta Neurologica Belgica, associate editor, since 2014.
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
(1)Sanofi (2)Roche (3)Novartis Pharma (4)Biogen (5) Merck (6) Almirall (6) BMS
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Sanofi (2) Roche (3) Novartis Pharma (4) Biogen
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
(1) Fondation Louvain (2) Charcot Foundation Belgium (3) Fonds National de la Recherche Scientifique
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Elisabetta Cartechini, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
I received speaking honoraria and travel grants from Novartis, Roche, Sanofi-Genzyme
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Suzanne Hodgkinson, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Commercial pharma MERCK Novartis Bayer Atara Biogen Roche
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
MERCK - Advisory boards, travel Novartis- Advisory boards, travel Biogen - Advisory boards, travel Roche - Advisory boards, travel Atara - Advisory boards, Travel
Editorial Boards:
1.
NONE
Patents:
1.
The role of cytokine IL-5 in antigen specific T cell tolerance
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Invited to record some podcasts reviewing MS literature by Novartis.
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Monitoring of activated Tcells in cladribine patients 75,0000 MerckC clinical trial funding by Biogen, Merck, Novartis, Sanofi, Atara
Research Support, Government Entities:
1.
NH&MRC project grant 2013-2016
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Aysun Soysal, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Albert Saiz, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
compensation for consulting services and speaker honoraria from Bayer-Schering, Merck-Serono, Biogen-Idec, Sanofi-Aventis, Teva Pharmaceutical Industries Ltd, Novartis, Alexion,and Roche
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Melissa Gresle, PhD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Conference travel support, Roche Australia.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
I currently work on studies funded by Biogen and Roche
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Merck - advisory board 1/2020
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Financial support for conference travel and speaker honoraria from Biogen Idec, Novartis, Roche, Sanofi and Merck Serono.
Editorial Boards:
1.
Activitas Nervosa Superior: Associate Editor from 2018 Journal of Neuroimaging: Editorial Board from 2020 Frontiers In Neurology: Review Editor from 2020 Frontiers In Behavioral Neuroscience: Review Editor from 2020
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Biogen Sanofi (GZ-2017-11718)
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
Charles University Grant Agency (GAUK) Czech Ministry of Education project Progres Czech Ministry of Health project AZV
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Davide Maimone, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Sanofi Genzyme, Teva, Merck, Roche, Novartis, Almirall
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Sanofi Genzyme, Roche, Merck, Novartis
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Raymond M.M. Hupperts, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
I have received honoraria for scientific Advisory boards from: Biogen-Idec, Merck, Genzyme-Sanofi.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
I have received Speaker's honoraria from; Biogen Idec, Genzyme-Sanofi and MERCK.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
I have received PhD financial support from Biogen-Idec and Merck.
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Maria Pia Amato, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
member of Advisory Boards for Biogen, Merck, Teva, Novartis, Sanofi Aventis, Genzyme, Almirall and Roche
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
honoraria for speaking from Biogen, Merck, Novartis, Teva, Genzyme, Almirall and Sanofi Aventis and Roche
Editorial Boards:
1.
Member of Editorial Board and Associate Editor of BMC Neurology Member of the Editorial Board and co-editor for Europe of Multiple Sclerosis Journal Member of the Editorial board of Frontiers in Neurology
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
research grants from Biogen, Merk, Bayer, Sanofi Aventis, Teva, Roche, Novartis
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Franco Granella, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1)Biogen(2) Novartis (3) Sanofi Genzyme (4) Merck Serono (5) Roche
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Biogen (2) Novartis (3) Merck Serono (4)Sanofi Genzyme (5) Roche
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Sanofi Genzyme (2) Biogen
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Celia Oreja-Guevara, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Biogen Idec (1), Sanofi-Genzyme(1), Merck-Serono (1), Roche (1), Celgene(1) and Novartis(1)
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Speaker honoraria by Sanofi-Genzyme (1), Merck-Serono (1),Celgene (1), Roche(1) and Novartis(1)
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Ayse Altintas, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
For Merck and Deva pharmaceutical companies as a scientific advisory board member
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
From Generica and TEVA, travel grants were received
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Richard A. Macdonell, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Novartis, Biogen,Sanofi-Genzyme,Merck, BMS, Roche
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Novartis, Biogen,Sanofi-Genzyme
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Tamara Castillo-Trivino, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
(1)Almirall (2)Biogen (3)Merck (4)Novartis (5)Roche (6)Sanofi-Genzyme.
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1)Almirall (2)Biogen (3)Merck (4)Novartis (5)Roche (6)Sanofi-Genzyme (7)Teva.
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
(1)Department of Health, Basque Country Government, #2018111038, PI, 2018-2021
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Helmut Butzkueven, PhD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Dr Butzkueven served on Scientific Advisory Boards and Study Steering Committees for the MSBase Foundation, Novartis, Biogen, Merck, Roche and Multiple Sclerosis Research Australia
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Dr Butzkueven's Institution has received support from Novartis, Alexion, Merck,Roche and Biogen (speaker and advisor honoraria)
Editorial Boards:
1.
Multiple Sclerosis and Related Disorders, Member, Editorial Board since 2011.
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Dr Butzkueven has a paid consultancy for the MS Brain Health Initiative steering committee duties and content creation with Oxford Health Policy Forum Dr Butzkueven's Institution receives income for his consultancy duties for Roche, Merck, Biogen and Novartis
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Dr Butzkueven's Institutions have received Research Support from Biogen, Roche, Merck and Novartis.
Research Support, Government Entities:
1.
He is the recipient of a National Health and Medical Research Council (NHMRC) Investigator Grant 2021-26, an NHMRC Project Grant (2018-21), a Monash Partners Medical Research Future Fund grant (2020- 21) and a Trish Foundation project Grant 2020-22).
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Dr Butzkueven's Institution has received research support from MS Research Australia, the Pennycook Foundation, the NHMRC, the MRFF, and Charityworks for MS
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Raed Alroughani, MD
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
Dr. Alroughani served in scientific advisory boards of Novartis, Bayer, Merck-Sorono, Roche, Biogen, Sanofi-Geznyme
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
Dr Alroughani received speaker and travel honoraria from Novartis, Bayer, Merck-Sorono, Biogen, Roche, Sanofi-Genzyme and GSK
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
Received research grant from Biogen, Novartis and Sanofi-Genzyme
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
(1) Merck Serono, funding for conference travel. (2) Biogen, speaker honoraria (3) Roche, funding for conference travel and speaker honoraria (4) Roche, speaker honoraria
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
National Health and Medical Research Council (NHMRC) of Australia Project Grant (1156519), Chief Investigator, 4 years
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
on behalf of the MSBase Study Group
From the Department of Neuroscience (W.Z.Y., P.A.W., A.V.d.W., J.S., M.G., H.B., V.G.J.), Central Clinical School, Monash University; Department of Neurology (W.Z.Y., A.V.d.W., O.G.S., M.G., H.B., V.G.J.), Alfred Health, Melbourne, Victoria, Australia; Department of Neurology and Center of Clinical Neuroscience (E.H., D.H., K.V., T.U.), First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Dokuz Eylul University (S.O.), Izmir, Turkey; Hospital Universitario Virgen Macarena (S.E.), Sevilla, Spain; CHUM–Hopital Notre Dame (P.D.), Montreal, Canada; CORe (T.K.), Department of Medicine, University of Melbourne; Melbourne MS Centre (T.K.), Royal Melbourne Hospital, Australia; Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia (F.P.), and AOU Policlinico-San Marco (F.P.), University of Catania, Sicily; KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey; Medical Faculty (M.T.), Mayis University, Samsun, Turkey; Faculty of Medicine (B.I.Y.), Nehme and Therese Multiple Sclerosis Center, American University of Beirut, Lebanon; John Hunter Hospital (J.L.-S.), Newcastle, Australia; Neurology Unit (P.S.), Azienda Ospedaliero-Universitaria of Modena, Italy; Brain and Mind Centre (M.B.), University of Sydney, Camperdown, Australia; Univ G.d’Annunzio Chieti-Pescara (M.O.), Chieti, Italy; Department of Neurology (M.J.S.), São João Universitary Hospital Center, Porto, Portugal; St. Andrews Place (P.A.M.), Spring Hill, Australia; Royal Brisbane and Women's Hospital (P.A.M.), Herston, Australia; Centre de réadaptation déficience physique Chaudière-Appalache (P.G.), Levis, Canada; Nemocnice Jihlava (R.A.), Czech Republic; Neuro Rive-Sud (F. Grand’Maison), Greenfield Park, Canada; IRCCS Mondino Foundation (R.B.), Pavia; AORN San Giuseppe Moscati Avellino (D.L.A.S.), Italy; Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Belgium; Ospedale Generale Provinciale Macerata (E.C.), Italy; Liverpool Hospital (S.H.), Australia; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A. Soysal), Istanbul, Turkey; Service of Neurology (A. Saiz), Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Institut de Neurociències (A. Saiz), Universitat de Barcelona, Spain; Centro Sclerosi Multipla (D.M.), UOC Neurologia, ARNAS Garibaldi, Catania, Italy; Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey; Maaslandziekenhuis (R.M.M.H.), Sittard, the Netherlands; Department NEUROFARBA (M.P.A.), University of Florence; IRCCS Fondazione Don Carlo Gnocchi (M.P.A.), Florence; University of Parma (F. Granella), Italy; Department of Neurology (C.O.-G.), Hospital Clínico San Carlos; Departamento de Medicina (C.O.-G.), Facultad de Medicina, Universidad Complutense de Madrid (UCM); IdISSC (C.O.-G.), Madrid, Spain; Department of Neurology (A.A.), Koc University School of Medicine, Istanbul, Turkey; Department of Neurology (R.A.M.), Austin Health, Heidelberg, Australia; Department of Neurology (T.C.-T.), Hospital Universitario Donostia, San Sebastian, Spain; Box Hill Hospital (H.B.), Australia; and Amiri Hospital (R.A.), Kuwait City, Kuwait.
Notes
Correspondence Dr. Jokubaitis [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
MSBase Study Group coinvestigators are listed at links.lww.com/WNL/B381.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Natalia Friedmann,
- Sandra Thiel,
- Kerstin Hellwig,
- I.V. Zakroyshchikova,
- T.O. Simaniv,
- D.O. Zemlyanaya,
- A.A. Timofeeva,
- M.N. Zakharova,
- Edith L. Graham,
- Riley Bove,
- Kathleen Costello,
- Heidi Crayton,
- Dina A. Jacobs,
- Suma Shah,
- Francesca Sorrell,
- Sharon S. Stoll,
- Maria K. Houtchens,
- Erin E. Kelly,
- Casey Engel,
- Rylan Pearsall,
- J. Nicholas Brenton,
- Riley Bove,
- Unsong Oh,
- Myla D. Goldman,
- Doriana Landi,
- Silvia Bartolomeo,
- Francesca Bovis,
- Maria Pia Amato,
- Simona Bonavita,
- Giovanna Borriello,
- Maria Buccafusca,
- Sebastiano Bucello,
- Paola Cavalla,
- Maria Cellerino,
- Diego Centonze,
- Eleonora Cocco,
- Antonella Conte,
- Antonio Cortese,
- Emanuele D’Amico,
- Massimiliano Di Filippo,
- Renato Docimo,
- Roberta Fantozzi,
- Elisabetta Ferraro,
- Massimo Filippi,
- Matteo Foschi,
- Antonio Gallo,
- Franco Granella,
- Antonio Ianniello,
- Roberta Lanzillo,
- Lorena Lorefice,
- Matteo Lucchini,
- Giacomo Lus,
- Giorgia Mataluni,
- Massimiliano Mirabella,
- Lucia Moiola,
- Francesca Napoli,
- Carolina Gabri Nicoletti,
- Francesco Patti,
- Paolo Ragonese,
- Sabrina Realmuto,
- Giuseppe Schirò,
- Elisabetta Signoriello,
- Leonardo Sinisi,
- Maria Laura Stromillo,
- Valentina Tomassini,
- Domizia Vecchio,
- Maria Pia Sormani,
- Girolama Alessandra Marfia,
- Jan Hillert,
- Riley Bove,
- Lisa B Haddad,
- Kerstin Hellwig,
- Maria Houtchens,
- Melinda Magyari,
- Gabriele S Merki-Feld,
- Scott Montgomery,
- Rossella E Nappi,
- Egon Stenager,
- Heidi Thompson,
- Zeliha Tulek,
- Elisabetta Verdun Di Cantogno,
- Manuela Simoni,
- Morgane Swital,
- Jérôme Drouin,
- Sara Miranda,
- Serge Bakchine,
- Jérémie Botton,
- Rosemary Dray-Spira,
- Satoshi Saito,
- Ryotaro Ikeguchi,
- Kazuo Kitagawa,
- Yuko Shimizu,
- Maria K. Houtchens,
- Elisa Matias Vieira de Melo,
- Bruno Cassis Antunes Rodrigues,
- Felipe Teijeiro Cabral,
- Luíza Alves Monteiro Torreão Villarim,
- Maria Fernanda Mendes,
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.